TickerFactsScreenerDevelopers

ALNYLAM PHARMACEUTICALS, INC. (ALNY) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2007: $105.16M2008: $191.79M2009: $137.47M2010: $74.60M2011: $70.23M2012: $51.41M2013: $53.17M2014: $75.18M2015: $180.90M2016: $193.62M2017: $645.36M2018: $420.15M2019: $547.18M2020: $496.58M2021: $819.98M2022: $866.39M2023: $812.69M2024: $966.43M2025: $1.66B$1.66B
2007Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$1.66B+71.5%
2024$966.43M+18.9%
2023$812.69M-6.2%
2022$866.39M+5.7%
2021$819.98M+65.1%
2020$496.58M-9.2%
2019$547.18M+30.2%
2018$420.15M-34.9%
2017$645.36M+233.3%
2016$193.62M+7.0%
2015$180.90M+140.6%
2014$75.18M+41.4%
2013$53.17M+3.4%
2012$51.41M-26.8%
2011$70.23M-5.9%
2010$74.60M-45.7%
2009$137.47M-28.3%
2008$191.79M+82.4%
2007$105.16M—